XML 42 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Grant Revenue
12 Months Ended
Dec. 31, 2018
Revenue From Contract With Customer [Abstract]  
Grant Revenue

12.

Grant Revenue

In February 2018, the Company received Small Business Innovation Research (“SBIR”) grants from the National Institutes of Health in an aggregate amount of $2.8 million to support the clinical development of PB1046 for the treatment of pulmonary arterial hypertension for the period from February 17, 2018 to July 31, 2020. In connection with the SBIR grants, the U.S. government will receive a non-exclusive, royalty-free license to use any technology the Company develops under such grants. The Company recognized $0.7 million under the SBIR grants in the year ended December 31, 2018. The Company did not recognize any grant revenues for the year ended December 31, 2017.